Brief: Pharmena Starts Second Pre-Clinical Trial To Determine Effective Dose Of 1-MNA Drug In SARS-CoV-2 Infection

Pharmena SA

21/01/2021 17:08

Jan 21 (Reuters) - Pharmena SA  PHR.WA :
    * STARTS SECOND PLANNED PRE-CLINICAL TRIAL ON ANIMAL MODELS
TO
DETERMINE EFFECTIVE TOLERABLE DOSE OF 1-MNA DRUG IN SARS-COV-2
INFECTION

Source text for Eikon:  ID:nEM4K6fPna 
Further company coverage:  PHR.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))